Israel: Bar-Ilan University develops molecular strategy to treat hematological cancer
November 14, 2021 / / Comments Off on Israel: Bar-Ilan University develops molecular strategy to treat hematological cancer
![Capture BIRAD - Research and Development Co. Ltd](https://birad.biz/wp-content/uploads/2021/11/Capture.jpg)
The study could provide an answer to types of hematological cancers for which no treatment has yet been found
Researchers at Bar-Ilan University in Israel have unveiled a new therapeutic approach in the fight against hematological cancer.
The new method, developed by Professor Mira Barda-Saad and her research team at the Mina and Everard Goodman Faculty of Life Sciences, involves attacking the cytoskeleton protein, called WASp, which has a unique structural condition in active hematological cancer cells.
To the article>>>
Posted in Press
Recent Comments